Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM

NCT06341595 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Gastric Cancer Metastatic to Regional Lymph Nodes

Interventions

DRUG: Sintilimab
RADIATION: Extraperitoneal radiation therapy
DRUG: Oxaliplatin
DRUG: S-1

Sponsor

The First Affiliated Hospital with Nanjing Medical University